Upregulation of IGF-1R Expression during Neoadjuvant Therapy Predicts Poor Outcome in Breast Cancer Patients

INTRODUCTION: The insulin-like growth factor 1 receptor (IGF-1R) may be involved in the development of resistance against conventional cancer treatment. The aim of this study was to assess whether IGF-1R expression of breast tumors changes during neoadjuvant therapy and to study whether these change...

Descripción completa

Detalles Bibliográficos
Autores principales: Heskamp, Sandra, Boerman, Otto C., Molkenboer-Kuenen, Janneke D. M., Wauters, Carla A., Strobbe, Luc J. A., Mandigers, Caroline M. P. W., Bult, Peter, Oyen, Wim J. G., van der Graaf, Winette T. A., van Laarhoven, Hanneke W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334229/
https://www.ncbi.nlm.nih.gov/pubmed/25680198
http://dx.doi.org/10.1371/journal.pone.0117745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334229/
https://www.ncbi.nlm.nih.gov/pubmed/25680198
http://dx.doi.org/10.1371/journal.pone.0117745

Ejemplares similares